Department of Economics, Federal University of Bahia, Salvador, Brazil.
Centre for Strategic Studies, Oswaldo Cruz Foundation, Rio de Janeiro, Brazil.
Artif Organs. 2021 Jan;45(1):79-87. doi: 10.1111/aor.13784. Epub 2020 Aug 15.
Patients with kidney failure can only survive with some form of kidney replacement (transplant or dialysis). Unfortunately, innovations in kidney replacement therapy lag behind many other medical fields. This study compiles expert opinions on candidate technologies for future kidney replacement therapies. A worldwide web-based survey was conducted with 1566 responding experts, identified from scientific publications on kidney (renal) replacement therapy, indexed in the Web of Science Core Collection (period 2014-2019). Candidate innovative approaches were categorized in line with the Kidney Health Initiative roadmap for innovative kidney replacement therapies. Most respondents expected a revolution in kidney replacement therapies: 68.59% before 2040 and 24.85% after 2040, while 6.56% expected none. Approaches anticipated as most likely were implantable artificial kidneys (38.6%) and wearable artificial kidneys (32.4%). A majority of experts expect that kidney replacement therapies can be significantly improved by innovative technologies.
肾衰竭患者只能通过某种形式的肾脏替代治疗(移植或透析)才能存活。不幸的是,肾脏替代疗法的创新落后于许多其他医学领域。本研究汇集了未来肾脏替代治疗候选技术的专家意见。通过在 Web of Science Core Collection 中索引的关于肾脏(肾)替代治疗的科学出版物,在全球范围内进行了一项基于网络的调查,共涉及 1566 名回复专家(2014-2019 年期间)。候选创新方法是根据肾脏健康倡议的创新肾脏替代治疗路线图进行分类的。大多数受访者预计肾脏替代疗法将发生革命性变化:2040 年前有 68.59%,2040 年后有 24.85%,而 6.56%的受访者预计不会有变化。预计最有可能的方法是可植入人工肾脏(38.6%)和可穿戴人工肾脏(32.4%)。大多数专家预计,通过创新技术可以显著改善肾脏替代疗法。